Juventas Cell Therapy Ltd.
PrivateLast Round
Series C
Oct 25, 2021
Est. Valuation
$263.04M
Total Funding Raised
$232.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Juventas Cell Therapy Ltd. is a biotechnology company that develops and manufactures innovative immune cell and gene therapies for the treatment of hematological malignancies and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juventas Cell Therapy Ltd. Comparables
Compare Juventas Cell Therapy Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hrain Biotechnology Co., Ltd. | 88% | |
| Imunopharm Technology Co., Ltd. | 87% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 86% | |
Juventas Cell Therapy Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 25, 2021 | ||||
| Series C | Jul 12, 2021 | ||||
| Series B | Nov 19, 2020 | ||||
| Series A Extension | Jul 9, 2019 | ||||
| Series A | Dec 17, 2018 |
Juventas Cell Therapy Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B |
| CCIC Capital | Series C |
| China International Capital Corporation | Series C |
| Dalton Venture | Series A, Series A Extension |
| Tianjin Venture Capital Management Co., Ltd. | Series C, Series B |
| Oceanpine Capital | Series C |
| Delian Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 65% MoM, reaching 2.7K.
- Oct 25, 2021
$63M round led by CCIC Capital and Oceanpine Capital.
Juventas Cell Therapy Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Juventas Cell Therapy Ltd.'s valuation, stock price, and market status.